Author:
Maio Michele,Scherpereel Arnaud,Calabrò Luana,Aerts Joachim,Perez Susana Cedres,Bearz Alessandra,Nackaerts Kristiaan,Fennell Dean A,Kowalski Dariusz,Tsao Anne S,Taylor Paul,Grosso Federica,Antonia Scott J,Nowak Anna K,Taboada Maria,Puglisi Martina,Stockman Paul K,Kindler Hedy L
Reference41 articles.
1. Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008;Delgermaa;Bull World Health Organ,2011
2. Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)-Medicare investigation of treatment patterns and overall survival;Beebe-Dimmer;Clin Epidemiol,2016
3. Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Baas;Ann Oncol,2015
4. Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial;Zalcman;Lancet,2016
5. Immune checkpoint blockade in cancer therapy;Postow;J Clin Oncol,2015
Cited by
367 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献